- Home
- FLOC vs JANX Comparison
FLOC vs JANX Comparison
Compare FLOC & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLOC
- JANX
- Stock Information
- Founded
- FLOC 1996
- JANX 2017
- Country
- FLOC United States
- JANX United States
- Employees
- FLOC N/A
- JANX N/A
- Industry
- FLOC Metal Fabrications
- JANX Biotechnology: Pharmaceutical Preparations
- Sector
- FLOC Industrials
- JANX Health Care
- Exchange
- FLOC Nasdaq
- JANX Nasdaq
- Market Cap
- FLOC 1.9B
- JANX 1.6B
- IPO Year
- FLOC 2025
- JANX 2021
- Fundamental
- Price
- FLOC $17.44
- JANX $23.60
- Analyst Decision
- FLOC Strong Buy
- JANX Strong Buy
- Analyst Count
- FLOC 5
- JANX 7
- Target Price
- FLOC $33.40
- JANX $94.29
- AVG Volume (30 Days)
- FLOC 402.7K
- JANX 808.2K
- Earning Date
- FLOC 08-06-2025
- JANX 08-06-2025
- Dividend Yield
- FLOC 0.46%
- JANX N/A
- EPS Growth
- FLOC N/A
- JANX N/A
- EPS
- FLOC 2.69
- JANX N/A
- Revenue
- FLOC $660,916,000.00
- JANX $9,336,000.00
- Revenue This Year
- FLOC $51.92
- JANX N/A
- Revenue Next Year
- FLOC $11.23
- JANX $1,470.82
- P/E Ratio
- FLOC $6.51
- JANX N/A
- Revenue Growth
- FLOC 156.58
- JANX 28.12
- 52 Week Low
- FLOC $15.83
- JANX $22.48
- 52 Week High
- FLOC $30.50
- JANX $71.71
- Technical
- Relative Strength Index (RSI)
- FLOC N/A
- JANX 41.60
- Support Level
- FLOC N/A
- JANX $24.45
- Resistance Level
- FLOC N/A
- JANX $27.28
- Average True Range (ATR)
- FLOC 0.00
- JANX 1.35
- MACD
- FLOC 0.00
- JANX -0.09
- Stochastic Oscillator
- FLOC 0.00
- JANX 22.20
About FLOC Flowco Holdings Inc. Class A Common Stock
Flowco Holdings Inc is a provider of production optimization, artificial lift and methane abatement solutions for the oil and natural gas industry. Its technologies include high pressure gas lift (HPGL), conventional gas lift, plunger lift and vapor recovery unit (VRU) solutions. The company operates in two reportable segments: Production Solutions which include rental services and Natural Gas Technologies which include service gas compression parts and equipment sales. Production Solutions: relates to rentals, sales and services related to high pressure gas lift, conventional gas lift and plunger lift; including other digital solutions and methane abatement technologies, and has maximum revenue.
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.